282 related articles for article (PubMed ID: 32853742)
1. The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice.
Zhu H; He YS; Ma J; Zhou J; Kong M; Wu CY; Mao Q; Lin G; Li SL
J Ethnopharmacol; 2021 Jan; 265():113271. PubMed ID: 32853742
[TBL] [Abstract][Full Text] [Related]
2. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.
Xi S; Peng Y; Minuk GY; Shi M; Fu B; Yang J; Li Q; Gong Y; Yue L; Li L; Guo J; Peng Y; Wang Y
J Ethnopharmacol; 2016 Aug; 190():1-12. PubMed ID: 27235019
[TBL] [Abstract][Full Text] [Related]
3. Complex components of Shengmai formula interact with organic cation transporter 2 (OCT2) in MDCK cells.
Meng C; Zhong L; Lu T; Gu Q; Du X; Liu F; Xia C
J Ethnopharmacol; 2023 May; 308():116278. PubMed ID: 36813246
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression.
Hu C; Lau AJ; Wang R; Chang TKH
Eur J Pharmacol; 2017 Nov; 815():501-511. PubMed ID: 29031898
[TBL] [Abstract][Full Text] [Related]
5. One-month toxicokinetic study of SHENMAI injection in rats.
Yu J; Xin YF; Gu LQ; Gao HY; Xia LJ; You ZQ; Xie F; Ma ZF; Wang Z; Xuan YX
J Ethnopharmacol; 2014 Jun; 154(2):391-9. PubMed ID: 24747029
[TBL] [Abstract][Full Text] [Related]
6. Identification of NF-κB inhibitors following Shenfu injection and bioactivity-integrated UPLC/Q-TOF-MS and screening for related anti-inflammatory targets in vitro and in silico.
Li P; Lv B; Jiang X; Wang T; Ma X; Chang N; Wang X; Gao X
J Ethnopharmacol; 2016 Dec; 194():658-667. PubMed ID: 27771457
[TBL] [Abstract][Full Text] [Related]
7. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
Xu R; Peng Y; Wang M; Fan L; Li X
J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
[TBL] [Abstract][Full Text] [Related]
8. The Synergistic Effects of Polysaccharides and Ginsenosides From American Ginseng (
Zhou R; He D; Xie J; Zhou Q; Zeng H; Li H; Huang L
Front Immunol; 2021; 12():665901. PubMed ID: 33968068
[TBL] [Abstract][Full Text] [Related]
9. Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms.
Fan W; Huang Y; Zheng H; Li S; Li Z; Yuan L; Cheng X; He C; Sun J
Biomed Pharmacother; 2020 Dec; 132():110915. PubMed ID: 33254433
[TBL] [Abstract][Full Text] [Related]
10. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
Shen H; Gao XJ; Li T; Jing WH; Han BL; Jia YM; Hu N; Yan ZX; Li SL; Yan R
J Ethnopharmacol; 2018 Apr; 216():47-56. PubMed ID: 29366768
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
[TBL] [Abstract][Full Text] [Related]
12. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach.
Zarneshan SN; Fakhri S; Khan H
Pharmacol Res; 2022 Mar; 177():106099. PubMed ID: 35092819
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
Lee SY; Jeong JJ; Eun SH; Kim DH
Eur J Pharmacol; 2015 Sep; 762():333-43. PubMed ID: 26054809
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of ginsenoside Rg1 on attenuating anti-GBM glomerular nephritis by activating NRF2 signalling.
Guo X; Zhang J; Liu M; Zhao GC
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2972-2979. PubMed ID: 31322005
[No Abstract] [Full Text] [Related]
15. A More Robust Gut Microbiota in Calorie-Restricted Mice Is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide.
Liu T; Wu Y; Wang L; Pang X; Zhao L; Yuan H; Zhang C
mBio; 2019 Mar; 10(2):. PubMed ID: 30862756
[TBL] [Abstract][Full Text] [Related]
16. Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action.
Zhu GX; Zuo JL; Xu L; Li SQ
Pharmacol Res; 2021 Jul; 169():105647. PubMed ID: 33964471
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma.
Zhang Q; Kang X; Zhao W
Biochem Biophys Res Commun; 2006 Apr; 342(3):824-8. PubMed ID: 16499874
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Fan J; Liu D; He C; Li X; He F
J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
[TBL] [Abstract][Full Text] [Related]
19. YiQiFuMai Powder Injection ameliorates the oxygen-glucose deprivation-induced brain microvascular endothelial barrier dysfunction associated with the NF-κB and ROCK1/MLC signaling pathways.
Cao GS; Chen HL; Zhang YY; Li F; Liu CH; Xiang X; Qi J; Chai CZ; Kou JP; Yu BY
J Ethnopharmacol; 2016 May; 183():18-28. PubMed ID: 26915982
[TBL] [Abstract][Full Text] [Related]
20. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
